Alcyomics Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Employees
-
13
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$2.82M
- Investors
-
1
Alcyomics General Information
Description
Operator of a pre-clinical assessment platform intended to support the pharmaceutical, biotechnology, and cosmetics industries. The company's platform offers sensitive detection of adverse immune reactions for preclinical testing of small- and large-molecule drugs and other compounds, enabling doctors and medical professionals to reduce risk and cost in the development of drugs and compounds.
Contact Information
Website
www.alcyomics.com(Operating Subsidiary)
Corporate Office
- The Biosphere, Draymans Way
- Newcastle Helix
- Newcastle upon Tyne NE4 5BX
- England, United Kingdom
Corporate Office
- The Biosphere, Draymans Way
- Newcastle Helix
- Newcastle upon Tyne NE4 5BX
- England, United Kingdom
Alcyomics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Merger/Acquisition | 05-Nov-2026 | $2.82M | Completed | Generating Revenue | ||
| 10. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 9. Accelerator/Incubator | 01-Jan-2023 | Completed | Generating Revenue | |||
| 8. Grant | 04-Aug-2020 | Completed | Generating Revenue | |||
| 7. Grant | 01-Jan-2022 | Completed | Generating Revenue | |||
| 6. Grant | 01-Mar-2018 | Completed | Generating Revenue | |||
| 5. Grant | 01-Aug-2017 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 21-Dec-2016 | Completed | Generating Revenue | |||
| 3. Grant | 15-Oct-2015 | $179K | Completed | Generating Revenue | ||
| 2. Grant | 03-Sep-2013 | $1.33M | Completed | Generating Revenue |
Alcyomics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| B Ordinary | ||||||||
| A Ordinary |
Alcyomics Patents
Alcyomics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4473095-A1 | An innervated cellular composite | Pending | 31-Jan-2022 | ||
| GB-202201229-D0 | An innervated cellular composite | Inactive | 31-Jan-2022 | ||
| US-20250163373-A1 | An innervated cellular composite | Pending | 31-Jan-2022 | ||
| WO-2023144567-A1 | An innervated cellular composite | Inactive | 31-Jan-2022 | ||
| EP-4463539-A1 | A cellular composite | Pending | 13-Jan-2022 | C12N5/0655 |
Alcyomics Signals
Alcyomics Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| EUREKA Network | Accelerator/Incubator | |||
| Innovate UK | Government | |||
| Newcastle University Endowment | Limited Partner | Minority | ||
| Northstar Ventures | Venture Capital | Minority | ||
| One North East | Government | Minority |
Alcyomics FAQs
-
When was Alcyomics founded?
Alcyomics was founded in 2007.
-
Where is Alcyomics headquartered?
Alcyomics is headquartered in Newcastle upon Tyne, United Kingdom.
-
What is the size of Alcyomics?
Alcyomics has 13 total employees.
-
What industry is Alcyomics in?
Alcyomics’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Alcyomics a private or public company?
Alcyomics is a Private company.
-
What is the current valuation of Alcyomics?
The current valuation of Alcyomics is .
-
What is Alcyomics’s current revenue?
The current revenue for Alcyomics is .
-
How much funding has Alcyomics raised over time?
Alcyomics has raised $564K.
-
Who are Alcyomics’s investors?
EUREKA Network, Innovate UK, Newcastle University Endowment, Northstar Ventures, and One North East are 5 of 6 investors who have invested in Alcyomics.
-
When was Alcyomics acquired?
Alcyomics was acquired on 05-Nov-2026.
-
Who acquired Alcyomics?
Alcyomics was acquired by SenzaGen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process